| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 35 |
| 1 | MYCOPHENOLATE MOFETIL | 24 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 24 |
| 3 | TACROLIMUS | 17 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 5 | TACROLIMUS OINTMENT 0.1% | 17 |
| 6 | METHYLPREDNISOLONE | 16 |
| 7 | TOCILIZUMAB | 14 |
| 8 | CYCLOPHOSPHAMIDE | 12 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 6 | 0.0007 |
| 2 | MICAFUNGIN SODIUM | 4 | 0.0006 |
| 3 | CEFADROXIL | 1 | 0.0005 |
| 4 | POSACONAZOLE | 7 | 0.0004 |
| 5 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 6 | REMDESIVIR | 5 | 0.0004 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 3 | 0.0004 |
| 8 | CEFEPIME HYDROCHLORIDE | 6 | 0.0004 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 3 | 0.0003 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 14 | 0.0001 |
| 7 | Antimalarial [EPC] | 1 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 12 | 0.0001 |